RecruitingGlioblastoma (GBM)
Music Therapy in Newly Diagnosed Glioblastoma After Chemoradiation Therapy (MELODY-GBM)
Eligible age
18+ yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The Brain Cancer Program, in partnership with the Center for Music and Medicine at Johns Hopkins, will study whether music therapy is feasible in newly diagnosed GBM patients undergoing standard care.
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
You may qualify if…
- ✓ Glioblastoma (Newly Diagnosed)
- ✓ Cognitive capacity to respond to surveys
- ✓ Access to computer and web access
- ✓ Ability to attend virtual music therapy sessions
- ✓ Audibly process music
- ✓ Proficient in English
You may not qualify if…
- ✕ Not planning to undergo standard of care radiation therapy and concurrent and adjuvant temozolomide.
- ✕ A life expectancy of less than 6 months.
- ✕ Concurrent use of any other standard or investigational agents (excepting tumor treating fields).
- ✕ Uncontrolled intercurrent illness including, but not limited to, ongoing or active infection or psychiatric illness/social situations that would limit adherence with study requirements.
Where it's recruiting
Maryland
Baltimore
Source: ClinicalTrials.gov · NCT07375992 · last updated 2026-06-18